Your browser doesn't support javascript.
loading
Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8+ Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results.
Ferrarotto, Renata; Bell, Diana; Rubin, Maria L; Hutcheson, Katherine A; Johnson, Jason M; Goepfert, Ryan P; Phan, Jack; Elamin, Yasir Y; Torman, Danice K; Warneke, Carla L; Hessel, Amy C; Garden, Adam S; Myers, Jeffrey N; Johnson, Faye M; Lee, J Jack; Sikora, Andrew G; Gillison, Maura L; Glisson, Bonnie S; Gross, Neil D.
Afiliação
  • Ferrarotto R; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. rferrarotto@mdanderson.org.
  • Bell D; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Rubin ML; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hutcheson KA; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Johnson JM; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Goepfert RP; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Elamin YY; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Torman DK; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Warneke CL; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hessel AC; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Myers JN; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Johnson FM; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lee JJ; The University of Texas MD Anderson Cancer Center Graduate School of Biomedical Sciences, Houston, Texas.
  • Sikora AG; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gillison ML; Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas.
  • Glisson BS; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gross ND; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 26(13): 3211-3219, 2020 07 01.
Article em En | MEDLINE | ID: mdl-32269052
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Orofaríngeas / Contagem de Linfócitos / Linfócitos T CD8-Positivos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Orofaríngeas / Contagem de Linfócitos / Linfócitos T CD8-Positivos Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article